A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats. (2022)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/17407745221110880
PubMed Identifier: 35866633
Publication URI: http://europepmc.org/abstract/MED/35866633
Type: Journal Article/Review
Volume: 19
Parent Publication: Clinical trials (London, England)
Issue: 6
ISSN: 1740-7745